Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview with Pål Ryfors (CEO, Episurf Medical)
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Interview with Pål Ryfors (CEO, Episurf Medical)
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
FDA Grants Orphan Drug Designation to Cardiol Therapeutics' Lead Candidate for Recurrent Pericarditis| David Elsley, CEO, Cardiol Therapeutics Inc.
00:10:00
David Garofalo on Juniors' Role in Gold Mining
00:10:00
Managing Market Shocks: Nahid Jetha on Portfolio Tail Risk Strategies | CEO, QTS Capital Management LLC
00:10:00
AML3D CEO Ryan Millar Discusses Strategic Reseller Agreement with Phillips Corporation | Ryan Millar , CEO, AML3D Ltd.
00:10:00
DrillCo's Revolutionary Clean Tech Modular Drilling System Unveiled
00:10:00
Unveiling eToro: A Decade of Financial Innovation | Yoni Assia , CEO, eToro.
00:10:00
Exploring Bond Markets and Chinese Equity: Opportunities and Strategies | Bill Maldonado, CEO , Eastspring Investments.
00:00:00
Timothy Morris - CFO, Head of Business Development, AcelRx Pharmaceuticals Inc
00:10:00
helping our portfolio companies grow their businesses and our operating teams|David Haber,General Partner,Andreessen Horowitz
00:10:00
Choosing a Financial Planner: Key Criteria, Fees, and Next Steps
00:10:00
Navigating the Digital Energy Transition: Exploring the Role of Smart Networks and Power-to-Gas Initiatives | Paolo Gallo, CEO, Italgas SpA.
00:10:00
Strategic Investment Insights Amid Geopolitical and Economic Uncertainty